In recent statements, the USA government announced plans to impose a 100 per cent tariff on branded pharmaceutical products from firms that have not established USA-based manufacturing, unless construction of such facilities has already begun.
Tariff Risk Pharma USA | 29/09/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy